{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:24:56Z","timestamp":1761719096432,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sickle cell disease and oculocutaneous albinism are rare autosomal recessive disorders both related to mutations on chromosome 11. The diagnosis of patients suffering from both pathologies is necessary to enable dedicated monitoring of any complications at the ophthalmic and skin level. However, few cases are described in the literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 14-month-old Congolese male child affected by oculocutaneous albinism, presented with pallor and jaundice. Blood indices revealed severe hemolytic anemia, which led to the diagnosis of sickle cell disease. The patient received a blood transfusion and close follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The co-inheritance of sickle cell disease and oculocutaneous albinism is a reality in the Democratic Republic of Congo, although it is rarely described. Given the current state of our knowledge, specific surveillance, specifically regarding cutaneous and ophthalmological complications, should be offered in this particular population. To enable this dedicated follow-up, sensitization to screening for sickle cell anemia in albino individuals should be carried out.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13256-021-03214-5","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T17:02:21Z","timestamp":1639933341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3535-8438","authenticated-orcid":false,"given":"Beno\u00eet","family":"Mbiya Mukinayi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mpoyi Kalenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Kalombo Kalenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghislain","family":"Disashi Tumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Gulbis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,19]]},"reference":[{"key":"3214_CR1","doi-asserted-by":"publisher","first-page":"193252","DOI":"10.1155\/2013\/193252","volume":"2013","author":"J Makani","year":"2013","unstructured":"Makani J, Ofori-Acquah SF, Nnodu O, Wonkam A, Ohene-Frempong K. Sickle cell disease: new opportunities and challenges in Africa. ScientificWorldJournal. 2013;2013:193252.","journal-title":"ScientificWorldJournal"},{"key":"3214_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0151-9638(07)89250-7","volume":"134","author":"C Rooryck","year":"2007","unstructured":"Rooryck C, Morice F, Mortemousque B, Lacombe D, Ta\u00efeb A, Arveiler B. Albinisme oculo-cutan\u00e9. Ann Dermatol Venereol. 2007;134:55\u201364.","journal-title":"Ann Dermatol Venereol"},{"key":"3214_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.mehy.2011.01.029","volume":"76","author":"MO Bakare","year":"2011","unstructured":"Bakare MO. Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)\u2013does hypermelanotic or hypomelanotic skin status of affected patients play a role? Med Hypotheses. 2011;76:673\u20135.","journal-title":"Med Hypotheses"},{"key":"3214_CR4","doi-asserted-by":"crossref","unstructured":"Chakravorty S, Williams TN. Sickle cell disease: A neglected chronic disease of increasing global health importance [Internet]. Archives of Disease in Childhood. 2015 [cited 2018 Nov 15]. https:\/\/www.mendeley.com\/catalogue\/sickle-cell-disease-neglected-chronic-disease-increasing-global-health-importance\/.","DOI":"10.1136\/archdischild-2013-303773"},{"key":"3214_CR5","first-page":"1349","volume":"192","author":"G Tchernia","year":"2008","unstructured":"Tchernia G, Bardakdjian J, Lain\u00e9 A, Ly A, Orssaud G, Larnaudie S. A center in Paris for screening and counselling sickle cell patients and carriers. Bull Acad Natl Med. 2008;192:1349\u201360.","journal-title":"Bull Acad Natl Med"},{"key":"3214_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/pbc.24175","volume":"59","author":"B Aygun","year":"2012","unstructured":"Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer. 2012;59:386\u201390.","journal-title":"Pediatr Blood Cancer"},{"key":"3214_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12913-021-06286-7","volume":"21","author":"BM Mbiya","year":"2021","unstructured":"Mbiya BM, Kalombo DK, Mukendi YN, Daubie V, Mpoyi JK, Biboyi PM, et\u00a0al. Improvement of SCD morbimortality in children: experience in a remote area of an African country. BMC Health Serv Res. 2021;21:294.","journal-title":"BMC Health Serv Res"},{"key":"3214_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-3148.2009.00943.x","volume":"20","author":"B Agasa","year":"2010","unstructured":"Agasa B, Bosunga K, Opara A, Tshilumba K, Dupont E, Vertongen F, et\u00a0al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. 2010;20:62\u20135.","journal-title":"Transfus Med"},{"key":"3214_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.puhe.2007.12.005","volume":"122","author":"L Tshilolo","year":"2008","unstructured":"Tshilolo L, Kafando E, Sawadogo M, Cotton F, Vertongen F, Ferster A, et\u00a0al. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies. Public Health. 2008;122:933\u201341.","journal-title":"Public Health"},{"key":"3214_CR10","first-page":"612","volume":"67","author":"M De Montalembert","year":"2007","unstructured":"De Montalembert M, Tshilolo L. Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa? Med Trop. 2007;67:612\u20136.","journal-title":"Med Trop"},{"key":"3214_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1182\/blood-2016-09-702324","volume":"129","author":"PT McGann","year":"2017","unstructured":"McGann PT, Hernandez AG, Ware RE. Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood. 2017;129:155\u201361.","journal-title":"Blood"},{"key":"3214_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0248-8663(15)60002-9","volume":"36","author":"A Habibi","year":"2015","unstructured":"Habibi A, Arlet J-B, Stankovic K, Gellen-Dautremer J, Ribeil J-A, Bartolucci P, et\u00a0al. Recommandations fran\u00e7aises de prise en charge de la dr\u00e9panocytose de l\u2019adulte: actualization 2015. Rev Med Interne. 2015;36:53\u201384.","journal-title":"Rev Med Interne"},{"key":"3214_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/09286586.2020.1723114","volume":"27","author":"SA AlRyalat","year":"2020","unstructured":"AlRyalat SA, Nawaiseh M, Aladwan B, Roto A, Alessa Z, Al-Omar A. Ocular manifestations of sickle cell disease: signs symptoms and complications. Ophthalmic Epidemiol. 2020;27:259\u201364.","journal-title":"Ophthalmic Epidemiol"},{"key":"3214_CR14","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/bjophthalmol-2018-312305","volume":"103","author":"GC Martin","year":"2019","unstructured":"Martin GC, Albuisson E, Brousse V, de Montalembert M, Bremond-Gignac D, Robert MP. Paramacular temporal atrophy in sickle cell disease occurs early in childhood. Br J Ophthalmol. 2019;103:906\u201310.","journal-title":"Br J Ophthalmol"},{"key":"3214_CR15","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1182\/blood-2016-12-755777","volume":"130","author":"M Dubert","year":"2017","unstructured":"Dubert M, Elion J, Tolo A, Diallo DA, Diop S, Diagne I, et\u00a0al. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa. Blood. 2017;130:2215\u201323.","journal-title":"Blood"},{"key":"3214_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.lpm.2017.05.020","volume":"46","author":"B Arveiler","year":"2017","unstructured":"Arveiler B, Lasseaux E, Morice-Picard F. Clinical and genetic aspects of albinism. Presse Med. 2017;46:648\u201354.","journal-title":"Presse Med"},{"key":"3214_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1172-2-43","volume":"2","author":"K Gr\u00f8nskov","year":"2007","unstructured":"Gr\u00f8nskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43.","journal-title":"Orphanet J Rare Dis"},{"key":"3214_CR18","unstructured":"L\u00e9sions cutan\u00e9es observ\u00e9es dans l\u2019albinisme oculo-cutan\u00e9\u202f: r\u00e9sultats d\u2019une campagne de d\u00e9pistage dans la ville\u2014province de Kinshasa [Internet]. Annales africaines de m\u00e9decine. 2017 [cited 2019 Jul 11]. https:\/\/anafrimed.net\/lesions-cutanees-observees-lalbinisme-oculo-cutane-resultats-dune-campagne-de-depistage-ville-province-de-kinshasa\/."},{"key":"3214_CR19","unstructured":"Les albinos de RDC entre ombre et lumi\u00e8re\u2014La Libre [Internet]. [cited 2019 Jul 11]. https:\/\/www.lalibre.be\/international\/les-albinos-de-rdc-entre-ombre-et-lumiere-52cfef283570105ef7e96482."},{"key":"3214_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.11604\/pamj.2020.35.127.21113","volume":"35","author":"P Kambale-Kombi","year":"2020","unstructured":"Kambale-Kombi P, Djang\u2019eing\u2019a RM, Alworong\u2019a Opara J-P, Wa Inena GI, Falay Sadiki D, Boemer F, et\u00a0al. Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo. Pan Afr Med J. 2020;35:127.","journal-title":"Pan Afr Med J"},{"key":"3214_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1471-2458-6-212","volume":"6","author":"ES Hong","year":"2006","unstructured":"Hong ES, Zeeb H, Repacholi MH. Albinism in Africa as a public health issue. BMC Public Health. 2006;6:212.","journal-title":"BMC Public Health"},{"key":"3214_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10038-007-0181-y","volume":"52","author":"R Aquaron","year":"2007","unstructured":"Aquaron R, Soufir N, Berg\u00e9-Lefranc J-L, Badens C, Austerlitz F, Grandchamp B. Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene. J Hum Genet. 2007;52:771\u201380.","journal-title":"J Hum Genet"},{"key":"3214_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12288-014-0333-0","volume":"30","author":"MK El-Ghamrawy","year":"2014","unstructured":"El-Ghamrawy MK, El Behairy HF, El Menshawy A, Awad SA, Ismail A, Gabal MS. Ocular manifestations in Egyptian children and young adults with sickle cell disease. Indian J Hematol Blood Transfus. 2014;30:275\u201380.","journal-title":"Indian J Hematol Blood Transfus."},{"key":"3214_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jaapos.2008.10.008","volume":"13","author":"BR Kutzbach","year":"2009","unstructured":"Kutzbach BR, Merrill KS, Hogue KM, Downes SJ, Holleschau AM, MacDonald JT, et\u00a0al. Evaluation of vision-specific quality-of-life in albinism. J AAPOS. 2009;13:191\u20135.","journal-title":"J AAPOS"},{"key":"3214_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/OPX.0b013e3181a5254c","volume":"86","author":"CG Summers","year":"2009","unstructured":"Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci. 2009;86:659.","journal-title":"Optom Vis Sci"},{"key":"3214_CR26","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.jcrs.2015.05.037","volume":"41","author":"A Farahi","year":"2015","unstructured":"Farahi A, Hashemi H, Mehravaran S. Combined cataract surgery and aniridia ring implantation in oculocutaneous albinism. J Cataract Refract Surg. 2015;41:2438\u201343.","journal-title":"J Cataract Refract Surg"},{"key":"3214_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/JMDH.S90630","volume":"10","author":"F Menaa","year":"2017","unstructured":"Menaa F, Khan BA, Uzair B, Menaa A. Sickle cell retinopathy: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:335\u201346.","journal-title":"J Multidiscip Healthc"},{"key":"3214_CR28","unstructured":"N.Y KCD MD, Brooklyn. Albinism: what you can do for your patients [Internet]. [cited 2019 Jul 14]. https:\/\/www.reviewofophthalmology.com\/article\/albinism-what-you-can-do-for-your-patients."},{"key":"3214_CR29","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/IAE.0000000000002321","volume":"30","author":"S Roemer","year":"2019","unstructured":"Roemer S, Bergin C, Kaeser P-F, Ambresin A. Assessment of macular vasculature of children with sickle cell disease compared to that of healthy controls using optical coherence tomography angiography. Retina. 2019;30:2384\u201391.","journal-title":"Retina"},{"key":"3214_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.det.2010.08.015","volume":"29","author":"AE Cruz-Inigo","year":"2011","unstructured":"Cruz-Inigo AE, Ladizinski B, Sethi A. Albinism in Africa: stigma, slaughter and awareness campaigns. Dermatol Clin. 2011;29:79\u201387.","journal-title":"Dermatol Clin"},{"key":"3214_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1365-4632.2009.04017.x","volume":"48","author":"ME Asuquo","year":"2009","unstructured":"Asuquo ME, Ngim O, Ebughe G, Bassey EE. Skin cancers amongst four Nigerian albinos. Int J Dermatol. 2009;48:636\u20138.","journal-title":"Int J Dermatol"},{"key":"3214_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/MOP.0000000000000514","volume":"29","author":"AL Fogel","year":"2017","unstructured":"Fogel AL, Sarin KY, Teng JMC. Genetic diseases associated with an increased risk of skin cancer development in childhood. Curr Opin Pediatr. 2017;29:426\u201333.","journal-title":"Curr Opin Pediatr"},{"key":"3214_CR33","doi-asserted-by":"publisher","first-page":"e8545","DOI":"10.1371\/journal.pone.0008545","volume":"5","author":"A Kalantri","year":"2010","unstructured":"Kalantri A, Karambelkar M, Joshi R, Kalantri S, Jajoo U. Accuracy and reliability of pallor for detecting anaemia: a hospital-based diagnostic accuracy study. PLoS ONE. 2010;5:e8545.","journal-title":"PLoS ONE"},{"key":"3214_CR34","unstructured":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.\u2014PubMed\u2014NCBI [Internet]. [cited 2019 Jul 11]. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23103089."},{"key":"3214_CR35","first-page":"127","volume":"9","author":"RW Massie","year":"1957","unstructured":"Massie RW, Hartmann RC. Albinism and sicklemia in a Negro family. Am J Hum Genet. 1957;9:127\u201332.","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03214-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T04:34:56Z","timestamp":1674102896000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3214"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03214-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The report of this case was submitted and approved by the Ethics Committee of the Faculty of Medicine of Mbujimayi University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"628"}}